Nicolas Vertadier, Wojciech Trzepizur, & Sébastien Faure. (2022). Overuse of Short-Acting Beta-2 Agonists (SABAs) in Elite Athletes: Hypotheses to Explain It. MDPI AG.
Chicago Style (17th ed.) CitationNicolas Vertadier, Wojciech Trzepizur, and Sébastien Faure. Overuse of Short-Acting Beta-2 Agonists (SABAs) in Elite Athletes: Hypotheses to Explain It. MDPI AG, 2022.
MLA (9th ed.) CitationNicolas Vertadier, et al. Overuse of Short-Acting Beta-2 Agonists (SABAs) in Elite Athletes: Hypotheses to Explain It. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.